Breaking News

ACRO Appoints Global Regulatory VP

By Kristin Brooks | March 20, 2014

Noonan to build relationships with regulators and alliance partners

Karen A. Noonan has been appointed vice president of Global Regulatory Policy at the Association of Clinical Research Organizations (ACRO). Ms. Noonan most recently served as senior advisor for health policy at Onyx Pharmaceuticals. Prior to that she was director of State Government Affairs and Grassroots Advocacy at the American Society of Health System Pharmacists (ASHP).
 
“We welcome Karen to the ACRO team and are confident she will continue to build our relationships with regulators and alliance partners in the United States, Europe and around the globe,” said ACRO executive director Doug Peddicord, Ph.D. “We see a tremendous opportunity for CROs to take a more pro-active position in regulatory policy as our members play an increasingly important role in medical product development.”
 
Additionally, John Lewis will serve as senior vice president, policy and public affairs. Mr. Lewis previously served as vice president of Public Affairs with the association.

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016